Management of restless legs and periodic movements of sleep;Prise en charge des impatiences et des mouvements périodiques au cours du sommeil

Revue Neurologique

Volumn 160, Issue 6-7, 2004, Pages 739-744

  Monaca, C ^a   Derambure, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Dopaminergic agonist; Periodic leg movements; Restless legs syndrome

Indexed keywords

ANTICONVULSIVE AGENT; BENSERAZIDE PLUS LEVODOPA; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE MESILATE; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; OPIATE; PERGOLIDE MESILATE; ROPINIROLE;

DIAGNOSTIC ERROR; DOPAMINERGIC SYSTEM; HUMAN; MOTOR DYSFUNCTION; PERIODIC LEG MOVEMENT; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SLEEP;

EID: 3843101426     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(04)71029-2     Document Type: Review

References (26)

1. BONNET M, CARLEY D, CARSKADON M et al. (1993). ASDA report: Recording and scoring leg movements. Sleep, 16: 749-759.
2. CHESSON AL, WISE M, DAVILA D et al. (1999). Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the Academy of Sleep Medicine. Sleep, 22: 961-968.
3. COLEMAN RM. (1982). Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C, Editor. Sleeping and Waking disorders: Indications and Techniques, Menlo Park: Addison-Wesley: p. 265-295.
4. COMELLA CL. (2002). Restless legs syndrome. Treatment with dopaminergic agents. Neurology, 58: S87-S92.
5. DESAUTELS A, TURECKI G, MONTPLAISIR J, BRISEBOIS K, SEQUEIRA A, ADAM B, ROULEAU GA. (2002a). Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology, 59: 215-219.
6. DESAUTELS A, MICHAUD M, MONTPLAISIR J, TURECKI G, ROULEAU GA. (2002b). Actualités Sixièmes Journées des Maladies du Système Nerveux périphérique. Syndrome d'impatiences musculaires de l'éveil: aspects cliniques, éléments d'étiologie et perspectives génétiques. Rev Neurol (Paris), 158: 1225-1231.
7. EARLEY C, YAFFEE J, ALLEN R. (1998). Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology, 51: 1599-1602.
8. GARCIA-BORREGUERO D, LARROSA O, DE LA LLAVE Y, VERGER K, MARASMON X, HERNANDEZ G. (2002). Treatment of restless legs syndrome with gabapentine. A double-blind, cross-over study. Neurology, 59: 1573-1579.
9. GEMIGNANI F, MARBINI A, DI GIOVANNI G, SALIH S, TERZANO MG. (1999). Charcot-Marie-Tooth disease type 2 with restless legs syndrome. Neurology, 52: 1064-1066.
10. HEINING W, ALLEN R, EARLEY C, KUSHIDA C, PICCHIETTI D, SILBER M. (1999). The treatment of restless legs syndrome and periodic limb movement disorder. Sleep, 22: 970-999.
11. HORNYAK M, KOTTERBA S, TRENKWALDER C AND MEMBERS OF THE WORKING GROUP MOTOR SYSTEM AND SLEEP OF THE GERMAN SLEEP SOCIETY. (2002). Consensus Statement from the German Sleep Society: indications for performing polysomnography in the diagnosis and treatment of restless legs syndrome. Sleep Med, 3: 457-458.
12. LAVIGNE GJ, MONTPLAISIR J. (1994). Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep, 17: 739-743.
13. MONTAGNA P, COCCAGNA G, CIRIGNOTTA F, LUGARESI E. (1983). Familial restless legs-syndrome: long term follow-up. In: Guilleminault C, Lugaresi E, editors. Sleep/wake disorders: natural history, epidemiology, and long-term evolution, New-York: Raven: p. 231-235.
14. MONTPLAISIR J, BOUCHER S, NICOLAS A, LESPERANCE P, GOSSELIN A, ROMPRE P, LAVINE G. (1998). Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord, 13: 324-329.
15. MONTPLAISIR J, NICOLAS A, DENESLE R, GOMEZ-MANCILLA B. (1999). Restless legs syndrome improved by pramipexole. A double-blind randomized trial. Neurology, 52: 938-943.
16. th ed. Berlin: Karger: p 1774.
17. SALETU B, GRUBER G, SALETU M et al. (2000). Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. I. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology, 41: 181-189.
18. SALETU M, ANDERER P, SALETU-ZYHLARZ G et al. (2001). Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). Acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol, 11: 153-161.
19. Schenck CH, Mahowald MW. (1996). Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med, 100: 333-337.
20. STLASNY K, WETTER TC, TRENKWALDER C, OERTEL WH. (2001). Restless legs syndrome and its treatment by dopamine agonists. Parkinsonism and related Disorders, 7: 21-25.
21. TELSTAD W, SORENSEN O, LARSEN S, LILLEVOLD PE, STENSRUD P, NYBERG-HANSEN R. (1984). Treatment of the restless legs syndrome with carbamazepine: a double blind study. Br Med J (Clin Res Ed), 288: 444-446.
22. 11C-raclopride PET studies. Neurology, 52: 932-937.
23. TRENKWALDER C, STIASNY K, POLLMÄCHER T et al. (1995). L-Dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep, 18: 681-688.
24. WALTERS A. (1995). Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord, 10: 634-642.
25. WALTERS A. (2002). Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. Sleep Med, 3: 301-304.
26. WETTER T, STIASNY K, WINKELMANN J et al. (1999). A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology, 52: 944-950.